0
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Long-term Outcome of Adjuvant Chemotherapy with MVP-CAB Regimen (Methotrexate, Vincristine, Cisplatin, Cyclophosphamide, Adriamycin and Bleomycin) for Locally Advanced Bladder Cancer

, , , &
Pages 151-156 | Received 29 Aug 2004, Accepted 02 Sep 2004, Published online: 16 Jul 2015

References

References

  • Gschwend , JE , Fair , WR and Vieweg , J . 2000 . Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies . Eur. Urol. , 38 : 121 – 130 .
  • Cheng L Weaver AL Leibovich BC et al. 2000 Predicting the survival of bladder carcinoma patients treated with radical cystectomy Cancer 88 2326 2332
  • Wijkstrom H Norming U Lagerkvist M et al. 1998 Evaluation of clinical staging before cystectomy in transitional cell carcinoma: a long-term follow-up of 276 consecutive patients Br. J. Urol. 81 686 691
  • Stenberg CN Yagoda A Scher HI et al. 1985 Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium J. Urol. 133 403 407
  • Logothetis CJ Samuels ML Ogden S et al. 1985 Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases J. Urol. 134 460 464
  • Logothetis CJ Johnson DE Chong C et al. 1988 Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update J. Clin. Oncol. 6 1590 1596
  • Skinner DG Daniels JR Russel CA et al. 1991 The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial J. Urol. 145 459 467
  • Freiha , F , Reese , J and Torti , FM . 1996 . A randomized trial of radical cystectomy versus partial cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer . J. Urol. , 155 : 495 – 500 .
  • Igawa M Urakami S Shiina H et al. 1995 Long-term results with M-VAC for advanced urothelial cancer: high response rate and low survival in patients with a complete response Br. J. Urol. 76 321 324
  • Miyake H Gohji K Hara I et al. 1999 Long-term results of neoadjuvant treatment with M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for locally invasive transitional cell carcinoma of the urothelium Int. J. Clin. Oncol. 4 32 35
  • Loehrer PJ Sr. Einhorn LH Elson PJ et al. 1992 A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J. Clin. Oncol. 10 1066 1073
  • Logothetis CJ Dexeus FH Finn L et al. 1990 A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors J. Clin. Oncol. 8 1050 1055
  • Gohji K Higuchi A Maruyama S et al. 1993 Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristin, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report Jpn J. Clin. Oncol. 23 291 298
  • Gohji K Ono Y Takenaka A et al. 1999 Long-term follow-up results of a pilot phase II study of multidrug chemotherapy (MVP-CAB) in patients with advanced urothelial cancer Jpn J. Clin. Oncol. 29 204 208
  • International Union Against Cancer 1997 TNM Classification of Malignant Tumors, John Wiley & Sons New York
  • Mostofi FK Davis CJ Sesterhenn IA 1999 Histological Typing of Urinary Bladder Tumours, Springer Verlag Berlin
  • Winquist E Kirchner TS Segal R et al. 2004 Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis J. Urol. 171 561 569
  • Millikan R Dinney C Swanson D et al. 2001 Integrated therapy for locally advanced bladder cancer: final report of a randomized trail of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC J. Clin. Oncol. 19 4005 4013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.